Back to search
FDAFDA · Food and drugs·Recall number D-1261-2014

Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA

Published April 30, 2014 · Recall initiated: March 27, 2014

Summary

FDA records drug Class II recall D-1261-2014, published April 30, 2014 and initiated March 27, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 255,900 vials; Lot: Lot 22-127-DK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 22-127-DK
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA recalled?

Yes. FDA published recall D-1261-2014 on April 30, 2014. Reported hazard: Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide

What should I do if I have this product?

Voluntary: Firm initiated · Letter